1-methyl-1-[3-methyl-4-[[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea
C26H24F3N7O4S — CID 118514006
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-methyl-1-[3-methyl-4-[[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea
1-methyl-1-[3-methyl-4-[[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea (PubChem CID 118514006) has the molecular formula C26H24F3N7O4S and a molecular weight of 587.58 g/mol. Its IUPAC name is 1-methyl-1-[3-methyl-4-[[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea.
Molecular Properties
| Compound Name | 1-methyl-1-[3-methyl-4-[[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea |
|---|---|
| PubChem CID | 118514006 |
| Molecular Formula | C26H24F3N7O4S |
| Molecular Weight | 587.58 g/mol |
| Exact Mass | 587.16 |
| IUPAC Name | 1-methyl-1-[3-methyl-4-[[2-(3-sulfamoylanilino)pyrimidin-4-yl]amino]phenyl]-3-[4-(trifluoromethoxy)phenyl]urea |
| SMILES | Cc1cc(N(C)C(=O)Nc2ccc(OC(F)(F)F)cc2)ccc1Nc1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1 |
| InChI | InChI=1S/C26H24F3N7O4S/c1-16-14-19(36(2)25(37)33-17-6-9-20(10-7-17)40-26(27,28)29)8-11-22(16)34-23-12-13-31-24(35-23)32-18-4-3-5-21(15-18)41(30,38)39/h3-15H,1-2H3,(H,33,37)(H2,30,38,39)(H2,31,32,34,35) |
| InChIKey | CFIIYKLQDRCTGV-UHFFFAOYSA-N |
| XLogP | 5.49 |
| TPSA | 151.57 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 587.58 |
| LogP ≤ 5 | 5.49 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118514006 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.